Clinical Study

Retinoblastoma in the Democratic Republic of Congo: 20-Year Review from a Tertiary Hospital in Kinshasa

Table 3

Regimens, courses, duration, and followup of chemotherapy for retinoblastoma over time.

RegimenYearsnMean 𝑛 of chemotherapy courses (ranges)Followup from start of treatment (months)

C/wk1995–199083.6 (2–6)1
VC-enu-VC19911129
VC/wk1991–199685.5 (5–6)3
VC-Prednisolone19921121 days
VC-VAC+M1996224.5 (6-43)10
VAC+M/3 wks1997–200045.25 (1–12)5
VAC/3 wks1998–2005143.1 (1–6)6
VMC-VAC-enu-200311615
VAC+VMC/3 wk20041113

C: cyclophosphamide; V: vincristine; A: Adriamycine; M: methotrexate; enu: enucleation.